Article Text

PDF
Sodium valproate reassessed

Abstract

Sodium valproate (Epilim - Labaz) is an effective anticonvulsant which has been used in the treatment of most forms of epilepsy. It has been taken by nearly a million people (70,000 in the UK) and during its first 10 years reported unwanted effects were few and mild.1 The recent reports of severe liver damage and other serious unwanted effects are disturbing.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.